A major breakthrough in cancer investigation is arising with the use of mini-antibodies to reactivate dysfunctional p53. This vital cancer suppressor protein is frequently disabled in many kinds of tumors, causing https://atozbookmark.com/story21796030/mini-antibodies-revive-p53-the-promising-hope-for-malignant-therapy